Genus (LON:GNS – Free Report) had its price objective boosted by Deutsche Bank Aktiengesellschaft from GBX 3,100 to GBX 3,300 in a research note released on Friday morning,Digital Look reports. The brokerage currently has a buy rating on the stock.
Several other research analysts have also commented on the stock. Shore Capital reaffirmed a “buy” rating and issued a GBX 3,000 price target on shares of Genus in a report on Friday. Berenberg Bank raised their target price on shares of Genus from GBX 3,050 to GBX 3,250 and gave the stock a “buy” rating in a report on Friday. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of GBX 3,183.33.
Get Our Latest Report on Genus
Genus Stock Performance
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Stories
- Five stocks we like better than Genus
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
